cyclohexene has been researched along with mk 6892 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, TQ; Carballo-Jane, E; Chen, Q; Cheng, K; Colletti, SL; Deng, Q; Ding, FX; Forrest, MJ; Hammond, ML; Holt, TG; Krsmanovic, ML; Luell, S; Raghavan, S; Ren, N; Shen, HC; Taggart, AK; Tata, JR; Tong, X; Wang, J; Waters, MG; Wilsie, LC; Wolff, MS; Wu, KK; Wu, TJ | 1 |
1 other study(ies) available for cyclohexene and mk 6892
| Article | Year |
|---|---|
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate.
Topics: Animals; Area Under Curve; Binding, Competitive; Carboxylic Acids; CHO Cells; Cricetinae; Cricetulus; Cyclohexanecarboxylic Acids; Cyclohexenes; Dogs; Drug Discovery; Drug Evaluation, Preclinical; Fatty Acids, Nonesterified; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Chemical; Molecular Structure; Oxadiazoles; Rats; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Structure-Activity Relationship; Vasodilation | 2010 |